Shannon Carty is a Hematology physician affiliated with University of Michigan. OpenAlex indexes 66 publications with 3,191 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
63.4%Corticosteroid39.4%Prednisone100%Part D<11 patientsSerotonin-3 Receptor Antagonist23.9%Ondansetron Hcl100%Part D<11 patientsNervous system
19.7%Phenothiazine19.7%Prochlorperazine Maleate100%Part D<11 patientsDermatology
16.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor16.9%Acyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- The role for ER associated degradation (ERAD) in T cell homeostasis and memory
University of Michigan at Ann Arbor
FY2026$508,357R01AI165533 - The role for ER associated degradation (ERAD) in T cell homeostasis and memory
University of Michigan at Ann Arbor
FY2025$493,107R01AI165533 - The role for ER associated degradation (ERAD) in T cell homeostasis and memory
University of Michigan at Ann Arbor
FY2024$584,595R01AI165533
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction
The Journal of Immunology
2026 - Origins of T‐cell‐mediated autoimmunity in acquired aplastic anaemia
British Journal of Haematology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Joshua Ehrlich, MD
University of Michigan
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Jaroslaw Maciejewski, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”